English
|
Spanish
Login
Register
For the latest
e
cancer COVID-19 resources, click on this link
Home
News
Journal
Video
e
learning
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Conferences
Sign up for latest coverage
Submit your event
Conferences
e
cancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Past
Upcoming
Category
All
Disease Areas
Patient Care
Policy
Prevention & screening
Treatments
Sub-category
All
Region
All
Asia
Middle East and North Africa
Europe
North America
Central America and the Caribbean
South America
Africa
Australia and Oceania
Country
All
Year
All
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Keyword
2018 ASCO Annual Meeting
1 - 5 Jun 2018
McCormick Place, Chicago, United States of America
Videos
News
ASCO 2018 conference round up
Dr Bishal Gyawali and Will Davies
24 Jun 2018
Repurposing selective PDE5 inhibitors as anti-cancer agents
Dr Pan Pantziarka - Anticancer Fund, Brussels, Belgium
5 Jun 2018
First results of DREAM trial of frontline durvalumab for mesothelioma
Prof Anna Nowak - The University of Western Australia, Perth, Australia
5 Jun 2018
Results from the phase I ICONIC trial
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
4 Jun 2018
Chemotherapy plus durvalumab in triple negative breast cancer
Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany
4 Jun 2018
Phase II results of olaparib and abiraterone for mCRPC
Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK
4 Jun 2018
Global treatment pattern variations in HCC
Dr Nahum Mendez-Sanchez - Medica Sur Clinic and Foundation, Mexico City, Mexico
4 Jun 2018
Design and interim safety analysis of GeparX trial
Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany
4 Jun 2018
Key developments in non-metastatic and metastatic hormone-sensitive prostate can...
Dr Eleni Efstathiou, Prof Nicholas Mottet, Dr Andrew Armstrong and Prof Maria De...
4 Jun 2018
International cancer control plans
Dr Verna Vanderpuye - Korle Bu Teaching Hospital, Accra, Ghana
4 Jun 2018
Economic impact of NGS in non small cell lung cancer
Dr Nathan Pennell - Cleveland Clinic Cancer Center, Cleveland, USA
4 Jun 2018
Subcutaneous daratumumab shows benefit in patients with relapsed or refractory m...
Dr Ajai Chari - Mount Sinai Hospital, New York, USA
4 Jun 2018
Avelumab in combinations for lung cancer and update from ALEX study
Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
4 Jun 2018
Updates in melanoma from ASCO 2018
Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands
4 Jun 2018
Novel fusion proteins to target PD-L1 in HPV associated cancers
Dr James Gulley - Center for Cancer Research, Washington, USA
4 Jun 2018
Daratumumab in combination with carfilzomib and dexamethasone for relapsed multi...
Dr Ajai Chari - Mount Sinai Hospital, New York, USA
4 Jun 2018
Phase I study results of M7824 for patients with HPV associated cancers
Dr Julius Strauss - Center for Cancer Research, Washington, USA
4 Jun 2018
Phase III results of PROSPECT study for metastatic, castration-resistant prostat...
Dr James Gulley - Center for Cancer Research, Washington, USA
4 Jun 2018
Pancreatic survival improved with trial chemotherapy regimen after surgery
Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France
4 Jun 2018
Aspirin combined with acid-reducing medicine offers moderate benefits in patient...
Prof Janusz Jankowski - Royal College of Surgeons in Ireland, Dublin, Republic o...
4 Jun 2018
Pre-operative chemotherapy with radiation may help people with pancreatic cancer...
Dr Geertjan van Tienhoven - Academic Medical Center, Amsterdam, Netherlands
4 Jun 2018
Heated abdominal chemotherapy not beneficial in patients with advanced colorecta...
Dr Francois Quenet - Regional Cancer Institute, Montpellier, France
4 Jun 2018
Comment: Pancreatic cancer survival extended by over a year with chemotherapy re...
Dr Andrew Epstein and Prof Richard Schilsky
4 Jun 2018
Comment: Aspirin with acid-reducing medicine reduces chance of oesophageal cance...
Dr Andrew Epstein and Prof Richard Schilsky
4 Jun 2018
Comment: Improved 2 year survival for pancreatic cancer with pre-operative chemo...
Dr Andrew Epstein, Prof Richard Schilsky and Dr Geertjan van Tienhoven
4 Jun 2018
Comment: No benefit of heated abdominal chemotherapy in advanced colorectal canc...
Prof Richard Schilsky, Dr Andrew Epstein and Dr Francois Quenet
4 Jun 2018
Pancreatic cancer survival extended by over a year with chemotherapy regimen
Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France
4 Jun 2018
Aspirin with acid-reducing medicine reduces chance of oesophageal cancer in high...
Prof Janusz Jankowski - Royal College of Surgeons in Ireland, Dublin, Republic o...
4 Jun 2018
Improved 2 year survival for pancreatic cancer with pre-operative chemoradiation
Dr Geertjan van Tienhoven - Academic Medical Center, Amsterdam, Netherlands
4 Jun 2018
No benefit of heated abdominal chemotherapy in advanced colorectal cancer
Dr Francois Quenet - Regional Cancer Institute, Montpellier, France
4 Jun 2018
Dabrafenib halts growth of low-grade paediatric glioma
Dr Mark Kieran - Dana Farber Cancer Institue, Boston, USA
4 Jun 2018
ASCO 2018: Novel treatment strategies in prostate cancer therapeutics
Prof Karim Fizazi and Dr Neal Shore
4 Jun 2018
ASCO 2018: Latest developments in non-metastatic and metastatic castration-resis...
Dr Neal Shore, Dr Simon Chowdhury, Prof Matthew Smith and Prof Boris Hadaschik
3 Jun 2018
Finding appropriate doses for HER2 positive breast cancers
Dr Mariana Chavez-MacGregor - MD Anderson Cancer Center, Houston, USA
3 Jun 2018
Updates in targeted therapy for melanoma
Prof Dirk Schadendorf - Hospitals Essen-Mitte, Essen, Germany
3 Jun 2018
Education, collaboration and communication in global cancer control
Dr Susannah Stanway - Royal Marsden NHS Foundation Trust, London, UK
3 Jun 2018
Health related quality of life findings from COMBI-AD
Prof Dirk Schadendorf - Hospitals Essen-Mitte, Essen, Germany
3 Jun 2018
Developing a survivin vaccine for glioblastoma
Dr Michael Ciesielski - Roswell Park Comprehensive Cancer Center, Buffalo, USA
3 Jun 2018
Early results from a 3rd gen EGFR-TKI in advanced NSCLC
Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, the Republic of Korea
3 Jun 2018
New pathways in pancreatic cancer
Dr Federico Sanchez - Aurora Sheboygan Memorial Medical Center, Sheboygan, USA
3 Jun 2018
OPTIMISMM trial for refractory multiple myeloma
Dr Paul Richardson - Dana Farber Cancer Institue, Boston, USA
3 Jun 2018
Treatment updates in Merkel cell carcinoma
Dr Paul Nghiem - University of Washington, Seattle, USA
3 Jun 2018
Results from the LILAC study of ABP 980 with trastuzumab for HER2 early breast ...
Dr Hans-Christian Kolberg - Marienhospital Bottrop, Bottrop, Germany
3 Jun 2018
New treatment markers for myeloma
Dr Jesus San Miguel - Universidad de Navarra, Pamplona, Spain
3 Jun 2018
Most breast cancer patients could avoid chemo with use of genetic testing
Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA
3 Jun 2018
Pembrolizumab works better than chemotherapy alone as initial treatment for NSCL...
Dr Gilberto Lopes - Sylvester Comprehensive Cancer Center, Miami, USA
3 Jun 2018
Maintenance chemotherapy extends life for children with rare rhabdomyosarcoma
Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy
3 Jun 2018
Sunitinib with or without surgery for metastatic renal cell carcinoma
Prof Arnaud Mejean - Paris Descartes University, Paris, France
3 Jun 2018
Comment: Genetic testing of early breast tumours could allow patients to go with...
Dr Harold Burstein & Prof Richard Schilsky
3 Jun 2018
Comment: PD-1 immunotherapy better than chemo alone as first line lung cancer tr...
Dr John Heymach & Prof Richard Schilsky
3 Jun 2018
Comment: Paediatric rhabdomyosarcoma survival extended with maintenance chemothe...
Prof Richard Schilsky & Dr Gianni Bisogno
3 Jun 2018
Comment: Kidney surgery may be unneeded in many intermediate-risk patients
Dr Sumanta Pal & Prof Richard Schilsky
3 Jun 2018
Genetic testing of early breast tumours could allow patients to go without chemo
Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA
3 Jun 2018
PD-1 immunotherapy better than chemo alone as first line lung cancer treatment
Dr Gilberto Lopes - Oncoclinicas do Brasil, São Paulo, Brazil
3 Jun 2018
Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy
Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy
3 Jun 2018
Kidney surgery may be unneeded in many intermediate-risk patients
Prof Arnaud Mejean - Paris Descartes University, Paris, France
3 Jun 2018
ASCO 2018: Latest in bladder cancer treatments
Prof Thomas Powles & Prof Shahrokh Shariat
3 Jun 2018
Cancer treatment in the last 6 months of life: when inaction can outperform acti...
Dr Bishal Gyawali - Brigham and Women's Hospital, Boston, USA
3 Jun 2018
ASCO 2018: Integrating genomic data throughout treatment for prostate cancer
Prof Kurt Miller and Prof Bertrand Tombal
2 Jun 2018
A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER...
Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA
2 Jun 2018
Zoptarelin no better than doxarubicin for second-line advanced endometrial cance...
Dr David Miller - The University of Texas Southwestern Medical Center
2 Jun 2018
Improving global breast cancer care
Prof Carlos Barrios - Pontifica Universidade Catolica de Rio Grande do Sul, Braz...
2 Jun 2018
What will we expect from novel therapies for oesophageal and gastric malignancie...
Prof Ramon De Mello - University of Algarve, Faro, Portugal
2 Jun 2018
Nelarabine in newly diagnosed paediatric T-cell malignancies
Dr Kimberly Dunsmore - University of Virginia School of Medicine, Virginia, USA
2 Jun 2018
Immunotherapy trials and hyperprogressive disease
Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain
2 Jun 2018
First-in-human phase 1 study of TAK-931 for solid tumours
Dr Toshio Shimizu - National Cancer Center Hospital (NCCH), Tokyo, Japan
2 Jun 2018
Web-mediated follow-up via patient-reported outcomes vs. routine surveillance in...
Dr Fabrice Denis - Jean Bernard Centre, Le Mans, France
2 Jun 2018
The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for CL...
Prof William Wierda - MD Anderson Cancer Center, Houston, USA
2 Jun 2018
Development of blood tests for early lung cancer
Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA
2 Jun 2018
Linking Lynch Syndrome and microsatellite instability in tumours
Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA
2 Jun 2018
Matching personalised therapies to patients in the IMPACT trial
Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA
2 Jun 2018
Atezolizumab with chemotherapy improves PFS in squamous NSCLC
Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA
2 Jun 2018
Matching mutations in tumours to precision medicine improves survival
Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA
2 Jun 2018
Development of blood tests for early lung cancer
Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA
2 Jun 2018
Genomic study links several new cancers to Lynch Syndrome
Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA
2 Jun 2018
Taselisib with fulvestrant slows growth of advanced breast cancer
Dr José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA
2 Jun 2018
Atezolizumab with chemotherapy improves PFS in squamous NSCLC
Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA
2 Jun 2018
More from
e
cancer